GBD 2016 Neurology Collaborators. World, regional, and nationwide burden of neurological issues, 1990–2016: a scientific evaluation for the World Burden of Illness Examine 2016. Lancet. 2019, 18(5): 459–480.
Anjum A, Yazid MD, Fauzi Daud M, et al. Spinal twine harm: pathophysiology, multimolecular interactions, and underlying restoration mechanisms. Int J Mol Sci. 2020;21(20):7533.
Shah M, Peterson C, Yilmaz E, et al. Present developments within the administration of spinal twine harm: a complete evaluate of literature. Surg Neurol Int. 2020;11:2.
Li S, Liao R, Sheng X, et al. Hydrogen fuel in most cancers therapy. Entrance Oncol. 2019;9:696.
Wu C, Zou P, Feng S, et al. Molecular hydrogen: an rising therapeutic medical fuel for mind issues. Mol Neurobiol. 2023;60(4):1749–65.
Chin BY, Jiang G, Wegiel B, et al. Hypoxia-inducible issue 1alpha stabilization by carbon monoxide leads to cytoprotective preconditioning. Proc Natl Acad Sci USA. 2007;104(12):5109–14.
Mishra BB, Rathinam VAK, Martens GW, et al. Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome-dependent processing of IL-1β. Nat Immunol. 2013;14(1):52–60.
Ridnour LA, Thomas DD, Donzelli S, et al. The biphasic nature of nitric oxide responses in tumor biology. Antioxid Redox Sign. 2006;8(7–8):1329–37.
Khattak S, Zhang Q-Q, Sarfraz M, et al. The function of hydrogen sulfide in respiratory illnesses. Biomolecules. 2021;11(5):682.
Powell CR, Dillon KM, Matson JB. A evaluate of hydrogen sulfide (H2S) donors: chemistry and potential therapeutic purposes. Biochem Pharmacol. 2018;149:110–23.
Chen M, Li X, Shi Q, et al. Hydrogen sulfide publicity triggers hen trachea inflammatory harm by means of oxidative stress-mediated FOS/IL8 signaling. J Hazard Mater. 2019;368:243–54.
Jing H, Gao X, Xu L, et al. H2S promotes a glycometabolism dysfunction by disturbing the Th1/Th2 stability throughout LPS-induced irritation within the skeletal muscle groups of chickens. Chemosphere. 2019;222:124–31.
Rodkin S, Nwosu C, Sannikov A, et al. The function of hydrogen sulfide in regulation of cell dying following neurotrauma and associated neurodegenerative and psychiatric illnesses. Int J Mol Sci. 2023;24(13):10742.
Zafonte RD, Wang L, Arbelaez CA, et al. Medical fuel remedy for tissue, organ, and CNS safety: a scientific evaluate of results, mechanisms, and challenges. Adv Sci. 2022;9(13):e2104136.
Invernizzi M, de Sire A, Renò F, et al. Spinal twine harm as a mannequin of bone-muscle interactions: therapeutic implications from in vitro and in vivo research. Entrance Endocrinol. 2020;11:204.
Yang X, Hao D, Zhang H, et al. Remedy with hydrogen sulfide attenuates sublesional skeletal deterioration following motor full spinal twine harm in rats. Osteop Int. 2017;28(2):687–95.
Wang H, Wu Y, Han W, et al. Hydrogen sulfide ameliorates blood-spinal twine barrier disruption and improves purposeful restoration by inhibiting endoplasmic reticulum stress-dependent autophagy. Entrance Pharmacol. 2018;9:858.
Kesherwani V, Nelson KS, Agrawal SK. Impact of sodium hydrosulphide after acute compression harm of spinal twine. Mind Res. 2013;1527:222–9.
Xu C, Zhang M, Zhang G, et al. Hydrogen sulfide improves purposeful restoration in rat traumatic spinal twine harm mannequin by inducing nuclear translocation of NF-E2-related issue 2. Biol Pharm Bull. 2021;44(8):1093–100.
Wang J-F, Li Y, Music J-N, et al. Position of hydrogen sulfide in secondary neuronal harm. Neurochem Int. 2014;64:37–47.
Beck KD, Nguyen HX, Galvan MD, et al. Quantitative evaluation of mobile irritation after traumatic spinal twine harm: proof for a multiphasic inflammatory response within the acute to power setting. Mind. 2010;133(Pt 2):433–47.
Tamizhselvi R, Solar J, Koh Y-H, et al. Impact of hydrogen sulfide on the phosphatidylinositol 3-kinase-protein kinase B pathway and on caerulein-induced cytokine manufacturing in remoted mouse pancreatic acinar cells. J Pharmacol Exp Ther. 2009;329(3):1166–77.
Scheid S, Goeller M, Baar W, et al. Hydrogen sulfide reduces ischemia and reperfusion harm in neuronal cells in a dose- and time-dependent method. Int J Mol Sci. 2021;22(18):10099.
Nagasawa Ok, Tarui T, Yoshida S, et al. Hydrogen sulfide evokes neurite outgrowth and expression of high-voltage-activated Ca2+ currents in NG108-15 cells: involvement of T-type Ca2+ channels. J Neurochem. 2009;108(3):676–84.
Li L, Jiang H, Li Y, et al. Hydrogen sulfide protects spinal twine and induces autophagy through miR-30c in a rat mannequin of spinal twine ischemia-reperfusion harm. J Biomed Sci. 2015;22(1):50.
Kakinohana M, Marutani E, Tokuda Ok, et al. Respiratory hydrogen sulfide prevents delayed paraplegia in mice. Free Radical Biol Med. 2019;131:243–50.
Campolo M, Esposito E, Ahmad A, et al. A hydrogen sulfide-releasing cyclooxygenase inhibitor markedly accelerates restoration from experimental spinal twine harm. FASEB J. 2013;27(11):4489–99.
Wang R, Wu X, Tian Z, et al. Sustained launch of hydrogen sulfide from anisotropic ferrofluid hydrogel for the restore of spinal twine harm. Bioactive Supplies. 2023;23:118–28.
Wei S-W, Zou M-M, Huan J, et al. Position of the hydrogen sulfide-releasing donor ADT-OH within the regulation of mammal neural precursor cells. J Cell Physiol. 2022;237(7):2877–87.
Tardivo V, Crobeddu E, Pilloni G, et al. Say 《no》 to spinal twine harm: is nitric oxide an choice for therapeutic methods? Int J Neurosci. 2015;125(2):81–90.
Hamada Y, Ikata T, Katoh S, et al. Roles of nitric oxide in compression harm of rat spinal twine. Free Radical Biol Med. 1996;20(1):1–9.
Kwak EK, Kim JW, Kang KS, et al. The function of inducible nitric oxide synthase following spinal twine harm in rat. J Korean Med Sci. 2005;20(4):663–9.
Ju C, Ma Y-G, Zuo X-S, et al. Potential targets and mechanisms of photobiomodulation for spinal twine harm. Neural Regen Res. 2023;18(8):1782–8.
Bao T, Li N, Chen H, et al. Drug-Loaded Zwitterion-Primarily based Nanomotors for the Remedy of Spinal Twine Damage. ACS Appl Mater Interfaces. 2023;15(27):32762–71.
Nakahara S, Yone Ok, Setoguchi T, et al. Adjustments in nitric oxide and expression of nitric oxide synthase in spinal twine after acute traumatic harm in rats. J Neurotrauma. 2002;19(11):1467–74.
Osuka Ok, Watanabe Y, Takagi T, et al. Activation of endothelial nitric oxide synthase following spinal twine harm in mice. Neurosci Lett. 2008;436(2):265–8.
Zhao J-Y, Sheng X-L, Li C-J, et al. Metformin promotes angiogenesis and purposeful restoration in aged mice after spinal twine harm by adenosine monophosphate-activated protein kinase/endothelial nitric oxide synthase pathway. Neural Regen Res. 2023;18(7):1553–62.
Isaksson J, Farooque M, Olsson Y. Improved purposeful consequence after spinal twine harm in iNOS-deficient mice. Spinal Twine. 2005;43(3):167–70.
Farooque M, Isaksson J, Olsson Y. Improved restoration after spinal twine harm in neuronal nitric oxide synthase-deficient mice however not in TNF-alpha-deficient mice. J Neurotrauma. 2001;18(1):105–14.
Gao W, Li J. Focused siRNA supply reduces nitric oxide mediated cell dying after spinal twine harm. J Nanobiotechnol. 2017;15(1):38.
Erens C, Van Broeckhoven J, Hoeks C, et al. L-arginine depletion improves spinal twine harm through immunomodulation and nitric oxide discount. Biomedicines. 2022;10(2):205.
Pannu R, Singh I. Pharmacological methods for the regulation of inducible nitric oxide synthase: neurodegenerative versus neuroprotective mechanisms. Neurochem Int. 2006;49(2):170–82.
Wu L, Wang R. Carbon monoxide: endogenous manufacturing, physiological features, and pharmacological purposes. Pharmacol Rev. 2005;57(4):585–630.
Hopper CP, Meinel L, Steiger C, et al. The place is the scientific breakthrough of heme oxygenase-1 / carbon monoxide therapeutics? Curr Pharm Des. 2018;24(20):2264–82.
Farrugia G, Szurszewski JH. Carbon monoxide, hydrogen sulfide, and nitric oxide as signaling molecules within the gastrointestinal tract. Gastroenterology. 2014;147(2):303–13.
Zhang R-G, Yip C-Y, Ko W-H. Regulation of intracellular calcium by carbon monoxide in human bronchial epithelial cells. Cell Physiol Biochem. 2017;42(6):2377–90.
Levitt DG, Levitt MD. Carbon monoxide: a crucial quantitative evaluation and evaluate of the extent and limitations of its second messenger perform. Clin Pharmacol. 2015;7:37–56.
Grochot-Przeczek A, Dulak J, Jozkowicz A. Haem oxygenase-1: non-canonical roles in physiology and pathology. Clin Sci. 2012;122(3):93–103.
Gáll T, Pethő D, Nagy A, et al. Therapeutic potential of carbon monoxide (CO) and hydrogen sulfide (H2S) in hemolytic and hemorrhagic vascular disorders-interaction between the heme oxygenase and H2S-producing programs. Int J Mol Sci. 2020;22(1):47.
Chai J, Zhu J, Tian Y, et al. Carbon monoxide remedy: a promising technique for most cancers. J Mater Chem B. 2023;11(9):1849–65.
Wang B, Cao W, Biswal S, et al. Carbon monoxide-activated Nrf2 pathway results in safety in opposition to everlasting focal cerebral ischemia. Stroke. 2011;42(9):2605–10.
Choi YK, Maki T, Mandeville ET, et al. Twin results of carbon monoxide on pericytes and neurogenesis in traumatic mind harm. Nat Med. 2016;22(11):1335–41.
Dallas ML, Boyle JP, Milligan CJ, et al. Carbon monoxide protects in opposition to oxidant-induced apoptosis through inhibition of Kv2.1. FASEB J. 2011;25(5):1519–30.
Ryter SW, Ma KC, Choi AMK. Carbon monoxide in lung cell physiology and illness. Am J Physiol Cell Physiol. 2018;314(2):C211–27.
Harrington M. Two steps ahead in treating spinal twine harm. Lab Anim. 2012;42(1):8.
Motterlini R, Clark JE, Foresti R, et al. Carbon monoxide-releasing molecules: characterization of biochemical and vascular actions. Circ Res. 2002;90(2):E17-24.
de Rivero VJP. Carbon monoxide releasing molecule-3 inhibits inflammasome activation: A possible remedy for spinal twine harm. EBioMedicine. 2019;40:17–8.
Queiroga CSF, Vercelli A, Vieira HLA. Carbon monoxide and the CNS: challenges and achievements. Br J Pharmacol. 2015;172(6):1533–45.
Sharma HS, Alm P, Sjöquist PO, et al. A brand new antioxidant compound H-290/51 attenuates upregulation of constitutive isoform of heme oxygenase (HO-2) following trauma to the rat spinal twine. Acta Neurochir Suppl. 2000;76:153–7.
Sharma HS, Westman J, Gordh T, et al. Topical software of mind derived neurotrophic issue influences upregulation of constitutive isoform of heme oxygenase within the spinal twine following trauma an experimental research utilizing immunohistochemistry within the rat. Acta Neurochir Suppl. 2000;76:365–9.
Wang G, Hamid T, Keith RJ, et al. Cardioprotective and antiapoptotic results of heme oxygenase-1 within the failing coronary heart. Circulation. 2010;121(17):1912–25.
Zheng G, Zhan Y, Wang H, et al. Carbon monoxide releasing molecule-3 alleviates neuron dying after spinal twine harm through inflammasome regulation. EBioMedicine. 2019;40:643–54.
Zheng G, Zheng F, Luo Z, et al. CO-releasing molecule (CORM)-3 ameliorates spinal cord-blood barrier disruption following harm to the spinal twine. Entrance Pharmacol. 2020;11:761.
Zheng G, Zhan Y, Wang H, et al. Corrigendum to 《Carbon monoxide releasing molecule-3 alleviates neuron dying after spinal twine harm through inflammasome regulation》 [EBioMedicine 40 (2019) 643–654]. EBioMedicine. 2022;75: 103709.
Joshi HP, Kumar H, Choi UY, et al. CORM-2-solid lipid nanoparticles keep integrity of blood-spinal twine barrier after spinal twine harm in rats. Mol Neurobiol. 2020;57(6):2671–89.
Glik J, Cholewka A, Stanek A, et al. Thermal imaging and planimetry analysis of the outcomes of power wounds therapy with hyperbaric oxygen remedy. Adv Clin Exp Med. 2019;28(2):229–36.
Somaa F. A evaluate of the appliance of hyperbaric oxygen remedy in alzheimer’s illness. J Alzheimer’s Dis. 2021;81(4):1361–7.
Gottfried I, Schottlender N, Ashery U. Hyperbaric oxygen treatment-from mechanisms to cognitive enchancment. Biomolecules. 2021;11(10):1520.
Solar L, Zhao L, Li P, et al. Impact of hyperbaric oxygen remedy on HMGB1/NF-κB expression and prognosis of acute spinal twine harm: a randomized scientific trial. Neurosci Lett. 2019;692:47–52.
Nasiry D, Khalatbary AR, Abdollahifar M-A, et al. SDF-1α loaded bioengineered human amniotic membrane-derived scaffold transplantation together with hyperbaric oxygen improved diabetic wound therapeutic. J Biosci Bioeng. 2022;133(5):489–501.
Baratz-Goldstein R, Toussia-Cohen S, Elpaz A, et al. Quick and delayed hyperbaric oxygen remedy as a neuroprotective therapy for traumatic mind harm in mice. Mol Cell Neurosci. 2017;83:74–82.
Huang L, Zhang Q, Fu C, et al. Results of hyperbaric oxygen remedy on sufferers with spinal twine harm: a scientific evaluate and meta-analysis of Randomized Managed Trials. J Again Musculoskelet Rehabil. 2021;34(6):905–13.
Ahmadi F, Zargari M, Nasiry D, et al. Synergistic neuroprotective results of hyperbaric oxygen and methylprednisolone following contusive spinal twine harm in rat. J Spinal Twine Med. 2022;45(6):930–9.
Geng C-Ok, Cao H-H, Ying X, et al. The consequences of hyperbaric oxygen on macrophage polarization after rat spinal twine harm. Mind Res. 2015;1606:68–76.
Han C, Lin L, Zhang W, et al. Hyperbaric oxygen preconditioning alleviates myocardial ischemic harm in rats. Exp Biol Med. 2008;233(11):1448–53.
Yang J, Wang G, Gao C, et al. Results of hyperbaric oxygen on MMP-2 and MMP-9 expression and spinal twine edema after spinal twine harm. Life Sci. 2013;93(25–26):1033–8.
Dayan Ok, Keser A, Konyalioglu S, et al. The impact of hyperbaric oxygen on neuroregeneration following acute thoracic spinal twine harm. Life Sci. 2012;90(9–10):360–4.
Zhao X, Zhao X, Wang Z. Synergistic neuroprotective results of hyperbaric oxygen and N-acetylcysteine in opposition to traumatic spinal twine harm in rat. J Chem Neuroanat. 2021;118: 102037.
Cheshmi H, Mohammadi H, Akbari M, et al. Human Placental Mesenchymal Stem Cell-derived Exosomes in Mixture with Hyperbaric Oxygen Synergistically Promote Restoration after Spinal Twine Damage in Rats. Neurotoxicity Analysis, 2023.
Keyhanifard M, Helali H, Gholami M, et al. Quercetin together with hyperbaric oxygen remedy synergistically attenuates harm development in traumatic spinal twine harm in a rat mannequin. J Chem Neuroanat. 2023;128: 102231.
Wilson JRF, Schiavo S, Middleton WJ, et al. The therapy of perioperative spinal twine harm with hyperbaric oxygen remedy: a case report. Backbone. 2020;45(17):E1127–31.
Tan J-W, Zhang F, Liu H-J, et al. Hyperbaric oxygen ameliorated the lesion scope and nerve perform in acute spinal twine harm sufferers: a retrospective research. Clin Biochem. 2018;53:1–7.
Zhang X, Chen C, Ma S, et al. Inhibition of monocyte chemoattractant peptide-1 decreases secondary spinal twine harm. Mol Med Rep. 2015;11(6):4262–6.
Wang Y, Li C, Gao C, et al. Results of hyperbaric oxygen remedy on RAGE and MCP-1 expression in rats with spinal twine harm. Mol Med Rep. 2016;14(6):5619–25.
Zhou Y, Su P, Pan Z, et al. Mixture remedy with hyperbaric oxygen and erythropoietin inhibits neuronal apoptosis and improves restoration in rats with spinal twine harm. Phys Ther. 2019;99(12):1679–89.
Liu M, Chen H, Tong M, et al. Results of ultra-early hyperbaric oxygen remedy on femoral calcitonin gene-related peptide and bone metabolism of rats with full spinal transection. Backbone. 2018;43(16):E919–26.
Smuder AJ, Turner SM, Schuster CM, et al. Hyperbaric oxygen therapy following mid-cervical spinal twine harm preserves diaphragm muscle perform. Int J Mol Sci. 2020;21(19):7219.
Re Ok, Gandhi J, Liang R, et al. Medical utility of ozone remedy and hyperbaric oxygen remedy in degenerative disc illness. Med Fuel Res. 2023;13(1):1–6.
Siglioccolo A, Gammaldi R, Vicinanza V, et al. Advance in hyperbaric oxygen remedy in spinal twine harm. Chinese language Journal of Traumatology = Zhonghua Chuang Shang Za Zhi, 2023: S1008–1275(23)00044–5.
Zhang Z, Li Q, Yang X, et al. Results of hyperbaric oxygen remedy on postoperative restoration after incomplete cervical spinal twine harm. Spinal Twine. 2022;60(2):129–34.
Iketani M, Ohsawa I. Molecular hydrogen as a neuroprotective agent. Curr Neuropharmacol. 2017;15(2):324–31.
Yoritaka A, Abe T, Ohtsuka C, et al. A randomized double-blind multi-center trial of hydrogen water for Parkinson’s illness: protocol and baseline traits. BMC Neurol. 2016;16:66.
Xue J-L, Music G-H, Qin S-C. Analysis advances on preventive and therapeutic results of hydrogen on cardiovascular and cerebrovascular illnesses and underlying mechanisms][J. Sheng Li Xue Bao: [Acta Physiologica Sinica]. 2018;70(5):557–64.
Liu Q, Li B-S, Music Y-J, et al. Hydrogen-rich saline protects in opposition to mitochondrial dysfunction and apoptosis in mice with obstructive jaundice. Mol Med Rep. 2016;13(4):3588–96.
Terasaki Y, Terasaki M, Shimizu A. Protecting results of hydrogen in opposition to irradiation. Curr Pharm Des. 2021;27(5):679–86.
Bai Y, Han Q, Dong B, et al. PPARα contributes to the therapeutic impact of hydrogen fuel in opposition to sepsis-associated encephalopathy with the regulation to the CREB-BDNF signaling pathway and hippocampal neuron plasticity-related gene expression. Mind Res Bull. 2022;184:56–67.
Wu Y, Yuan M, Music J, et al. Hydrogen fuel from irritation therapy to most cancers remedy. ACS Nano. 2019;13(8):8505–11.
Kou Z, Zhao P, Wang Z, et al. Acid-responsive H2-releasing Fe nanoparticles for protected and efficient most cancers remedy. J Mater Chem B. 2019;7(17):2759–65.
Ohsawa I, Ishikawa M, Takahashi Ok, et al. Hydrogen acts as a therapeutic antioxidant by selectively decreasing cytotoxic oxygen radicals. Nat Med. 2007;13(6):688–94.
Huang Y, Xie Ok, Li J, et al. Useful results of hydrogen fuel in opposition to spinal twine ischemia-reperfusion harm in rabbits. Mind Res. 2011;1378:125–36.
Chen X, Cui J, Zhai X, et al. Inhalation of hydrogen of various concentrations ameliorates spinal twine harm in mice by defending spinal twine neurons from apoptosis, oxidative harm and mitochondrial construction damages. Cell Physiol Biochem. 2018;47(1):176–90.
Zhou L, Wang X, Xue W, et al. Useful results of hydrogen-rich saline in opposition to spinal twine ischemia-reperfusion harm in rabbits. Mind Res. 2013;1517:150–60.
Chen C, Chen Q, Mao Y, et al. Hydrogen-rich saline protects in opposition to spinal twine harm in rats. Neurochem Res. 2010;35(7):1111–8.
Kimura A, Suehiro Ok, Mukai A, et al. Protecting results of hydrogen fuel in opposition to spinal twine ischemia-reperfusion harm. J Thorac Cardiovasc Surg. 2022;164(6):e269–83.
Luo S, Wu J, Qiu Y, et al. Hydrogen promotes the effectiveness of bone mesenchymal stem cell transplantation in rats with spinal twine harm. Stem Cells Int. 2023;2023:8227382.
Kayabaş M, Şahin L, Makav M, et al. Protecting impact of hydrogen-rich saline on spinal twine harm in rats. Prescription drugs (Basel, Switzerland). 2023;16(4):527.
Wang J-L, Zhang Q-S, Zhu Ok, et al. Hydrogen-rich saline injection into the subarachnoid cavity inside 2 weeks promotes restoration after acute spinal twine harm. Neural Regen Res. 2015;10(6):958–64.
Liu F-T, Xu S-M, Xiang Z-H, et al. Molecular hydrogen suppresses reactive astrogliosis associated to oxidative harm throughout spinal twine harm in rats. CNS Neurosci Ther. 2014;20(8):778–86.
Szabo C. Gasotransmitters in most cancers: from pathophysiology to experimental remedy. Nat Rev Drug Discovery. 2016;15(3):185–203.
He Q, Shi J. MSN anti-cancer nanomedicines: chemotherapy enhancement, overcoming of drug resistance, and metastasis inhibition. Adv Supplies. 2014;26(3):391–411.
Mohamed Isa ED, Ahmad H, Abdul Rahman MB, et al. Progress in mesoporous silica nanoparticles as drug supply brokers for most cancers therapy. Pharmaceutics. 2021;13(2):152.
Wang PG, Xian M, Tang X, et al. Nitric oxide donors: chemical actions and organic purposes. Chem Rev. 2002;102(4):1091–134.
Axthelm J, Hoffmann P, et al. Co-registered molecular logic gate with a CO-releasing molecule triggered by gentle and peroxide. J Am Chem Soc. 2017;139(14):4991–4.
Hutson PH, Donohoe TP, Curzon G. Neurochemical and behavioural proof for an agonist motion of 1-[2-(4-aminophenyl)ethyl]-4-(3-trifluoromethylphenyl)piperazine (LY 165163) at central 5-HT receptors. Eur J Pharmacol. 1987;138(2):215–23.
Marin A, Muniruzzaman M, Rapoport N. Mechanism of the ultrasonic activation of micellar drug supply. J Management Rel. 2001;75(1–2):69–81.
Postema M, Bouakaz A, ten Cate FJ, et al. Nitric oxide supply by ultrasonic cracking: some limitations. Ultrasonics. 2006;44(Suppl 1):e109-113.
Fan W, Bu W, Zhang Z, et al. X-ray radiation-controlled NO-release for on-demand depth-independent hypoxic radiosensitization. Angewandte Chemie. 2015;54(47):14026–30.
Jin Z, Wen Y, Xiong L, et al. Intratumoral H2O2-triggered launch of CO from a metallic carbonyl-based nanomedicine for environment friendly CO remedy. Chem Commun (Camb). 2017;53(40):5557–60.
Choi HW, Kim J, Kim J, et al. Mild-induced acid technology on a gatekeeper for sensible nitric oxide supply. ACS Nano. 2016;10(4):4199–208.
Zhang XF, Mansouri S, Mbeh DA, et al. Nitric oxide supply by core/shell superparamagnetic nanoparticle autos with enhanced biocompatibility. Langmuir. 2012;28(35):12879–85.
He Q. Precision fuel remedy utilizing clever nanomedicine. Biomaterials Sci. 2017;5(11):2226–30.
Motterlini R, Otterbein LE. The therapeutic potential of carbon monoxide. Nat Rev Drug Discovery. 2010;9(9):728–43.
García-Gallego S, Bernardes GJL. Carbon-monoxide-releasing molecules for the supply of therapeutic CO in vivo. Angewandte Chemie. 2014;53(37):9712–21.